Mark E. Gurney

Current Institution
Tetra Discovery Partners LLC

Scholar: 1982

Awarded Institution
The University of Chicago


Research Interests

Seeking the Causes of Neurological Disorders and Developing Treatments for These Disorders

Dr. Gurney is a widely-recognized authority on human neurodegenerative diseases and his research focuses on elucidating the molecular basis of disorders such as Lou GehrigDs disease and AlzheimerDs Disease. Prior to his present appointment at Pharmacia Upjohn, Dr. Gurney held faculty positions at University of Chicago and Northwestern University. In 1994, Dr. Gurney helped develop one of the first transgenic animal models for human neurodegenerative diseases, a mouse model of Amyotrophic Lateral Sclerosis in which the enzyme superoxide dismutase (SOD) was altered.  In 1999, Dr. Gurney and his associates identified a protein that may play a role in the progression of AlzheimerDs disease.